Search research articles
Contact Us
Filters
Showing results (271-280 of 286) with videos related to
Page
of 29
Sort By:
Transplantation Proceedings
|
August 1, 1996
Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption
K Oldhafer, G W Haller, A Kattner, et al.
Der Radiologe
|
February 1, 1992
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement]
M Galanski, E Schmoll, S Reichelt, et al.
Clinical Transplantation
|
June 1, 1995
Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
B Ringe, K Böker, H J Schlitt, et al.
Transplantation
|
October 15, 1998
Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study
T Kiuchi, K J Oldhafer, H J Schlitt, et al.
Transplantation
|
July 15, 1995
Backgrounds of early intragraft immune activation and rejection in liver transplant recipients. Impact of graft reperfusion quality
T Kiuchi, H J Schlitt, K J Oldhafer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 11, 1988
[Combined heart and kidney transplantation in terminal myocardial and renal insufficiency]
M J Jurmann, G Herrmann, K Frimpong-Boateng, et al.
Transplantation
|
October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients
M Winkler, G Haller, K Oldhafer, et al.
Therapeutic Drug Monitoring
|
January 8, 1998
Pitfalls in monitoring tacrolimus (FK 506)
F Braun, E Schütz, U Christians, et al.
Transplantation Proceedings
|
December 1, 1996
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus
F Braun, T Lorf, E Schütz, et al.
Transplantation Proceedings
|
June 24, 1998
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites
E Schütz, M Shipkova, V W Armstrong, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 286) with videos related to
Sort By:
Page
of 29
Transplantation Proceedings
|
August 1, 1996
Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption
K Oldhafer, G W Haller, A Kattner, et al.
Der Radiologe
|
February 1, 1992
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement]
M Galanski, E Schmoll, S Reichelt, et al.
Clinical Transplantation
|
June 1, 1995
Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
B Ringe, K Böker, H J Schlitt, et al.
Transplantation
|
October 15, 1998
Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study
T Kiuchi, K J Oldhafer, H J Schlitt, et al.
Transplantation
|
July 15, 1995
Backgrounds of early intragraft immune activation and rejection in liver transplant recipients. Impact of graft reperfusion quality
T Kiuchi, H J Schlitt, K J Oldhafer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 11, 1988
[Combined heart and kidney transplantation in terminal myocardial and renal insufficiency]
M J Jurmann, G Herrmann, K Frimpong-Boateng, et al.
Transplantation
|
October 27, 1996
A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients
M Winkler, G Haller, K Oldhafer, et al.
Therapeutic Drug Monitoring
|
January 8, 1998
Pitfalls in monitoring tacrolimus (FK 506)
F Braun, E Schütz, U Christians, et al.
Transplantation Proceedings
|
December 1, 1996
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus
F Braun, T Lorf, E Schütz, et al.
Transplantation Proceedings
|
June 24, 1998
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites
E Schütz, M Shipkova, V W Armstrong, et al.
Page
of 29